Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization-Reference-Cited by-同舟云学术

Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization

Published:2019-03-12 Issue:6 Volume:68 Page:1130-1142
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:Diabetes

Author:

Chen Xiaofang,Zhuo Shu,Zhu Tengfei,Yao Pengle,Yang Mengmei,Mei Hong,Li Na,Ma Fengguang,Wang Ji Ming,Chen Shiting,Ye Richard D.,Li Yu^ORCID,Le Yingying^ORCID

Funder

National Natural Science Foundation of China

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference48 articles.

1. Abdominal obesity and metabolic syndrome

2. Early onset type 2 diabetes: risk factors, clinical impact and management

3. Inflammatory mechanisms linking obesity and metabolic disease

4. Regulation of metabolism by the innate immune system

5. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Identification of Key Genes and Biological Pathways in Cardiac Arrest by Integrated Bioinformatics and Next Generation Sequencing Data Analysis;2024-08-19

2. Single-Cell RNA Sequencing Reveals a Unique Fibroblastic Subset and Immune Disorder in Lichen Sclerosus Urethral Stricture;Journal of Inflammation Research;2024-08

3. Role of formyl peptide receptor 2 in steatosis of L02 cells exposed to Mono‐(2‐ethylhexyl) phthalate;Environmental Toxicology;2024-04-10

4. Changed regulation of granulocyte NADPH oxidase activity in the mouse model of obesity-induced type 2 diabetes mellitus;Free Radical Biology and Medicine;2024-04

5. The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists;European Journal of Medicinal Chemistry;2024-02